New drug combo aims to stop prostate Cancer's return
NCT ID NCT05826509
Summary
This study is testing whether adding a medication called darolutamide to standard prostate cancer surgery works better than surgery alone for men with high-risk or locally advanced prostate cancer. About 240 participants will be randomly assigned to receive either just surgery or surgery plus darolutamide taken around the time of the operation. The main goal is to see if the drug combination helps keep the cancer from progressing to an incurable stage for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Bordeaux
Bordeaux, France
-
CHU Grenoble
Grenoble, France
-
CHU Lyon - Hôpital Edouard Herriot
Lyon, France
-
CHU Lyon - Sud
Pierre-Bénite, France
-
CHU Rennes
Rennes, France
-
CHU Toulouse
Toulouse, France
-
Chu Angers
Angers, France
-
Chu Henri Mondor
Créteil, France
-
Chu Tours - Hopital Bretonneau
Tours, France
-
Clinique La Croix Du Sud
Quint-Fonsegrives, France
-
Hopital Bichat - Ap-Hp
Paris, 75018, France
-
Hopital Claude Huriez
Lille, France
-
Hopital Europeen Georges-Pompidou
Paris, France
-
Hopital Foch
Suresnes, France
-
Hopital Paris Saint-Joseph
Paris, 75014, France
-
Hopital Pitie Salpetriere
Paris, France
-
Institut Bergonié
Bordeaux, France
-
Institut Mutualiste Montsouris
Paris, France
-
Institut Paoli-Calmettes
Marseille, France
-
Institut Universitaire Du Cancer Toulouse - Oncopole
Toulouse, France
Conditions
Explore the condition pages connected to this study.